Evidence map›Paper›PMID 37716885›Full record

ReviewTrends in cancer2023

Selenoproteins and tRNA-Sec: regulators of cancer redox homeostasis.

Stephen L DeAngelo, Balázs Győrffy, Markos Koutmos, Yatrik M Shah

Open access · greenAbstract readReview
In one paragraph

Review in Trends in cancer, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. tRNA modification enzyme-dependent redox homeostasis regulates synapse formation and memory.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Review
  16. Targeting ferroptosis opens new avenues in gliomas.International journal of biological sciences · 2024
    Review
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Stephen L DeAngeloDepartment of Cancer Biology, University of Michigan, Ann Arbor, MI, USA.
Balázs GyőrffyDepartment of Bioinformatics, Semmelweis University, Budapest, Hungary.
Markos KoutmosDepartment of Cancer Biology, University of Michigan, Ann Arbor, MI, USA; Department of Chemistry, University of Michigan, Ann Arbor, MI, USA; Program in Biophysics, University of Michigan, Ann Arbor, MI, USA.
Yatrik M ShahDepartment of Cancer Biology, University of Michigan, Ann Arbor, MI, USA; Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, MI, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA; Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA. Electronic address: shahy@umich.edu.
University of Michigan–Ann Arbor · USSemmelweis University · HU

Funding

Control of iron absorption by intestinal HIF2 in iron and hematological disordersR01DK095201 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAH, YATRIK M · 2012 to 2025
$5.7M
The role of HIF2alpha in colon carcinogenesisR01CA148828 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAH, YATRIK M · 2010 to 2025
$5.2M
Structural and functional basis for protein-based eukaryotic RNA processingR01GM117141 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Markos Koutmos · 2016 to 2026
$2.5M
Understanding the mechanisms of iron addiction in colon cancerR01CA245546 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAH, YATRIK M · 2020 to 2024
$2.3M
Role of the tRNA methyltransferase AlkBH8 in Colorectal CancerR21CA286898 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KOUTMOS, MARKOS · 2024 to 2025
$386k
NCI NIH HHS R01 CA148828NCI NIH HHS R01 CA245546NCI NIH HHS R21 CA286898NIDDK NIH HHS R01 DK095201NIGMS NIH HHS R01 GM117141
6 · The paper itself

Abstract

In the past two decades significant progress has been made in uncovering the biological function of selenium. Selenium, an essential trace element, is required for the biogenesis of selenocysteine which is then incorporated into selenoproteins. These selenoproteins have emerged as central regulators of cellular antioxidant capacity and maintenance of redox homeostasis. This review provides a comprehensive examination of the multifaceted functions of selenoproteins with a particular emphasis on their contributions to cellular antioxidant capacity. Additionally, we highlight the promising potential of targeting selenoproteins and the biogenesis of selenocysteine as avenues for therapeutic intervention in cancer. By understanding the intricate relationship between selenium, selenoproteins, and reactive oxygen species (ROS), insights can be gained to develop therapies that exploit the inherent vulnerabilities of cancer cells.

Indexed as

NeoplasmsSeleniumAntioxidantsHomeostasisHumansOxidation-ReductionRNA, TransferSelenocysteineSelenoproteinsAntioxidantsRNA, TransferSeleniumSelenocysteineSelenoproteinsferroptosisoxidative stressreactive oxygen speciesredoxseleniumselenoprotein

Identifiers

PMID37716885
PMCPMC10843386
OpenAlexW4386776803

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.